ArticleFrontiers in microbiomes2026
A generalized supervised contrastive learning framework for integrative multi-omics prediction models.
Article in Frontiers in microbiomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Advancements in multi-omics research have demonstrated the potential of integrating human microbiome and metabolomics data to better understand physiological processes and improve prediction accuracy in studies of human health. While conventional models utilizing single-omics data provide valuable perspectives, they often fail to capture the complexity of biological systems. Recent developments in supervised contrastive learning frameworks have enhanced predictive performance for categorical responses, yet limitations persist in extending these methods to continuous outcomes. A robust model capable of addressing these gaps could significantly enhance multi-omics predictions and provide new insights into complex biological interactions. Here, we present MB-SupCon-cont, a novel supervised contrastive learning framework designed for both categorical and continuous responses in multi-omics data. MB-SupCon-cont improves prediction accuracy by incorporating a generalized contrastive loss function that defines similarity and dissimilarity for continuous responses using three distance-based weighting methods. Through simulation studies and two real-world datasets for Type 2 Diabetes (T2D) and High-Fat Diet (HFD), we demonstrate that MB-SupCon-cont consistently achieves lower prediction errors than tuned conventional models, canonical correlation analysis, and autoencoder baselines, with most reaching statistical significance. We further provide a validation-based rule for selecting the weighting method and show that the learned embeddings align more closely with the response and recover known microbe and metabolite associations. The framework also provides superior representation learning and improves data visualization in lower-dimensional spaces. These findings suggest that MB-SupCon-cont is a powerful tool for general multi-omics prediction and may have broad applicability in biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.